Cargando…

How splicing confers treatment resistance in prostate cancer

A splice variant of the androgen receptor that drives prostate cancer resistance translocates into the nucleus using a different mechanism from the full-length receptor and exhibits distinct molecular properties once inside.

Detalles Bibliográficos
Autores principales: Konda, Prathyusha, Viswanathan, Srinivas R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398401/
https://www.ncbi.nlm.nih.gov/pubmed/35998026
http://dx.doi.org/10.7554/eLife.82070